Tecan Group AG TCHBF
Set alert
271.00 USD 0.00 0.00%
At close · Oct 30
249.40 Day range 249.40
155.25 52-week range 271.00
- YTD
- +69.85%
- 1 year
- +49.02%
- Open
- 249.40
- Prev close
- 271.00
- Mkt cap
- 3.34B
- Vol
- 1
- Avg vol
- 4
- EPS
- -11.54
- P/E
- 0.00
More statistics
- Low
- 249.40
- High
- 249.40
- Earnings
- Aug 11, 2026
6M chart
Events in this range
- Aug 11, 2026Earnings: —; estimate 3.11; surprise —%
Signals (16)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 12, 2026 | 2 weeks ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| RSI: Overbought | Sep 21, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 28, 2026 | 3 months ago |
| RSI: Overbought | Jul 10, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 25, 2026 | 4 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 12, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 2, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 26, 2026 | 5 months ago |
| RSI: Overbought | May 19, 2026 | 5 months ago |
| MACD: Sell Signal | May 8, 2026 | 5 months ago |
Next earnings
Aug 11, 2026
Expected Aug 11, 2026. Consensus EPS estimate 3.11.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 11, 2026 | Jun 30, 2026 | 3.11 | — | — | — |
| Mar 16, 2026 | Dec 31, 2025 | 4.28 | 5.37 | +1.09 | +25.47% |
| Aug 12, 2025 | Jun 30, 2025 | 3.16 | 1.77 | -1.39 | -43.99% |
| Mar 10, 2025 | Dec 31, 2024 | 4.03 | 3.89 | -0.14 | -3.47% |
| Aug 13, 2024 | Jun 30, 2024 | 4.94 | 1.95 | -2.99 | -60.53% |
| Feb 27, 2024 | Dec 31, 2023 | 6.85 | 7.18 | +0.33 | +4.82% |
News
- How to Invest in AI Drug Discovery
- Tecan Group AG (TCGGY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- Tecan Group AG (TCGGY) Q2 2026 Earnings Call Transcript
- Tecan Accelerates Data-Driven Lab Journey With Agentic AI Developments Powered by NVIDIA
- Tecan to create Data-Driven Labs with NVIDIA
- Tecan Group AG (TCGGY) Analyst/Investor Day Transcript
- Tecan Group AG (TCGGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q's Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control
- Tecan Group AG (TCHBF) Q2 2025 Earnings Call Transcript
- Tecan Group AG (TCHBF) Q4 2024 Earnings Call Transcript
Your note
Sign in to keep a note on TCHBF — it syncs with the Stock Master app.